NCT07208851 Developing a Booster Session for Problem Management Plus in the Bahamas: A Pilot Randomized Controlled Trial
| NCT ID | NCT07208851 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The New School |
| Condition | Depression Symptoms |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-10-16 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-10-16 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Therapists at the Grand Bahama Resilience Center (GBRC) will be trained to deliver Problem Management Plus (PM+), a WHO intervention. Then, those therapists will deliver PM+ (5 one-on-one skills-based sessions) to a total of 50 adult clients experiencing mild to moderate mental health difficulties (excluding anyone with cognitive difficulties or psychosis). Participants will complete (de-identified) self-report survey assessments before PM+, after PM+, 3 months later, and 6 months later. After receiving 5 sessions of PM+, participants will be randomized to either receive a one-time booster session of PM+ (to be co-created by the PI and the GBRC providers) three months later or to a control group which will receive a phone call reminding them that they will receive their third assessment soon.
Eligibility Criteria
Inclusion Criteria: * Adults of 18 years or above * English-speaking * A score of \<91 on Global Assessment of Functioning * Located in the Bahamas Exclusion Criteria: * ● Imminent suicide risk (assessed at screening using Columbia Suicide-Severity Rating Scale, see document titled " Screener updated 10-30- 24") * Severe mental disorder (e.g. psychotic disorders) * Severe cognitive impairment (e.g. severe intellectual disability or dementia)
Contact & Investigator
Adam Brown D Brown, PhD
STUDY CHAIR
The New School
Frequently Asked Questions
Who can join the NCT07208851 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07208851 currently recruiting?
Yes, NCT07208851 is actively recruiting participants. Contact the research team at mcenc047@newschool.edu for enrollment information.
Where is the NCT07208851 trial being conducted?
This trial is being conducted at Freeport, The Bahamas.
Who is sponsoring the NCT07208851 clinical trial?
NCT07208851 is sponsored by The New School. The principal investigator is Adam Brown D Brown, PhD at The New School. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.